PENNSYLVANIA, March 12 - PRINTER'S NO. 1500

THE GENERAL ASSEMBLY OF PENNSYLVANIA

SENATE BILL

No.

1186

Session of

2026

INTRODUCED BY BOSCOLA, J. WARD, COLLETT, TARTAGLIONE, DUSH,

PISCIOTTANO, CAPPELLETTI, ARGALL AND KEARNEY, MARCH 12, 2026

REFERRED TO HEALTH AND HUMAN SERVICES, MARCH 12, 2026

AN ACT

Amending the act of November 21, 2016 (P.L.1318, No.169),

entitled, as amended, "An act providing for pharmacy audit

procedures, for registration of pharmacy benefits managers

and auditing entities, for maximum allowable cost

transparency, for prescription drugs reimbursed under the

PACE and PACENET program and for pharmacy benefit managers

contract requirements and prohibited activities; and making

related repeals," in preliminary provisions, further

providing for definitions; and, in pharmacy benefits manager

contracts, providing for State pharmacy benefits manager.

The General Assembly of the Commonwealth of Pennsylvania

hereby enacts as follows:

Section 1. The definitions of "specialty drug" and "spread

pricing" in section 103 of the act of November 21, 2016

(P.L.1318, No.169), known as the Pharmacy Audit Integrity and

Transparency Act, added July 17, 2024 (P.L.852, No.77), are

amended to read:

Section 103. Definitions.

The following words and phrases when used in this act shall

have the meanings given to them in this section unless the

context clearly indicates otherwise:

* * *

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22